Skip to main content
SpringerLink
Log in

Dermatologic Emergencies in Oncologic Patients

  • Chapter
  • First Online:
Oncologic Emergency Medicine

  • 1389 Accesses

Abstract

Patients with cancer can present with a wide range of dermatologic manifestations related to their underlying malignancy. These skin manifestations can range from common, routine conditions to serious, even life-threatening diseases. Thus, it is critical for physicians caring for oncologic patients to have an understanding of various skin morphologies in order to quickly recognize concerning features and initiate appropriate work-up and treatment for their patients.

Marisa Kardos Garshick and Laura Levin contributed equally to this work.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol. 2003;149:1018–22.

    Article  CAS  PubMed  Google Scholar 

  2. Criado PR, Avancini J, Santi CG, Medrado AT, Rodrigues CE, de Carvalho JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses, and immune system. Isr Med Assoc J. 2012;14:577–82.

    PubMed  Google Scholar 

  3. Blazar B, White ES, Couriel D. Understanding chronic GVHD from different angles. Biol Blood Marrow Transplant. 2012;18:S184–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Harris AC, Ferrara JL, Levine JE. Advances in predicting acute GVHD. Br J Haematol. 2013;160:288–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. J Am Acad Dermatol. 2012;67:163.e1–12. quiz 75–6.

    Article  Google Scholar 

  6. Hook III EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295–7.

    Article  PubMed  Google Scholar 

  7. Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008;59:524–9.

    Article  PubMed  Google Scholar 

  8. Horn T. Antineoplastic chemotherapy, sweat and the skin. Arch Dermatol. 1997;133:905–6.

    Article  CAS  PubMed  Google Scholar 

  9. Canueto J, Meseguer-Yebra C, Roman-Curto C, Santos-Briz A, Fernandez-Lopez E, Fraile C, et al. Leukemic vasculitis: a rare pattern of leukemia cutis. J Cutan Pathol. 2011;38:360–4.

    Google Scholar 

  10. Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol. 2008;129:130–42.

    Article  PubMed  Google Scholar 

  11. Seckin D, Senol A, Gurbuz O, Demirkesen C. Leukemic vasculitis: an unusual manifestation of leukemia cutis. J Am Acad Dermatol. 2009;61:519–21.

    Article  PubMed  Google Scholar 

  12. Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–7.

    Article  PubMed  Google Scholar 

  13. Bhardwaj N, Craig TJ. Treatment of hereditary angioedema: a review. Transfusion. 2014;54:2989–96.

    Article  CAS  PubMed  Google Scholar 

  14. Wintenberger C, Boccon-Gibod I, Launay D, et al. Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol. 2014;178:112–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303:1436–42.

    Article  CAS  PubMed  Google Scholar 

  16. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol. 2008;46:79–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096–100.

    Article  CAS  PubMed  Google Scholar 

  18. Todd JK, Ressman M, Caston SA, Todd BH, Wiesenthal AM. Corticosteroid therapy for patients with toxic shock syndrome. JAMA. 1984;252:3399–402.

    Article  CAS  PubMed  Google Scholar 

  19. Norrby-Teglund A, Ihendyane N, Darenberg J. Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections. Scand J Infect Dis. 2003;35:683–9.

    Article  CAS  PubMed  Google Scholar 

  20. Wieselthier JS, Koh HK. Sezary syndrome: diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol. 1990;22:381–401.

    Article  CAS  PubMed  Google Scholar 

  21. Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in skin biopsies of benign inflammatory versus lymphomatous erythroderma. Br J Dermatol. 2014;171:499–504.

    Article  CAS  PubMed  Google Scholar 

  22. Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29:863–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21:370–5.

    Article  CAS  PubMed  Google Scholar 

  24. Chen CY, Huang SY, Tsay W, Yao M, Tang JL, Ko BS, et al. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001–2010. Int J Antimicrob Agents. 2012;40:533–8.

    Article  CAS  PubMed  Google Scholar 

  25. Villada G, Roujeau JC, Cordonnier C, et al. Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol. 1990;23:870–5.

    Article  CAS  PubMed  Google Scholar 

  26. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131:539–43.

    Article  CAS  PubMed  Google Scholar 

  27. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92–6.

    Article  CAS  PubMed  Google Scholar 

  28. Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133:1197–204.

    Article  CAS  PubMed  Google Scholar 

  29. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil. 2002;23:87–96.

    Article  CAS  PubMed  Google Scholar 

  30. Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013;69:187.e1–16. quiz 203–4.

    Article  CAS  Google Scholar 

  31. Huang YC, Li YC, Chen TJ. The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol. 2012;167:424–32.

    Article  CAS  PubMed  Google Scholar 

  32. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol. 2007;87:144–8.

    Article  CAS  PubMed  Google Scholar 

  33. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204:503–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zimmermann J, Bahmer F, Rose C, Zillikens D, Schmidt E. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges. 2010;8:598–606.

    PubMed  Google Scholar 

  35. Wang L, Bu D, Yang Y, Chen X, Zhu X. Castleman’s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet. 2004;363:525–31.

    Article  CAS  PubMed  Google Scholar 

  36. Hertl M, Zillikens D, Borradori L, et al. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges. 2008;6:366–73.

    Article  PubMed  Google Scholar 

  37. Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol. 2007;34:503–11.

    Article  CAS  PubMed  Google Scholar 

  38. Campsall PA, Laupland KB, Niven DJ. Severe meningococcal infection: a review of epidemiology, diagnosis, and management. Crit Care Clin. 2013;29:393–409.

    Article  PubMed  Google Scholar 

  39. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1–28.

    PubMed  Google Scholar 

  40. Quatresooz P, Pierard-Franchimont C, Arrese JE, Pierard GE. Clinicopathologic presentations of dermatomycoses in cancer patients. J Eur Acad Dermatol Venereol. 2008;22:907–17.

    Article  CAS  PubMed  Google Scholar 

  41. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules (Basel, Switzerland). 2014;19:1085–119.

    Article  CAS  Google Scholar 

  42. Bruns T, Breathnach S, Cox N, Griffiths C. Rook’s textbook of dermatology. Oxford: Wiley-Blackwell; 2010.

    Book  Google Scholar 

  43. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009;61:325–32.

    Article  PubMed  Google Scholar 

  44. Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol. 2014;26:96–8.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Stewart A. Warfarin-induced skin necrosis treated with protein C concentrate (human). Am J Health Syst Pharm. 2010;67:901–4.

    Article  PubMed  Google Scholar 

  46. Davis MD, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J Am Acad Dermatol. 2007;57:944–56.

    Article  PubMed  Google Scholar 

  47. Cooper JS, Allinson P, Keim L, et al. Hyperbaric oxygen: a useful adjunct for purpura fulminans: case report and review of the literature. Undersea Hyperb Med. 2014;41:51–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA

    Marisa Kardos Garshick MD, Laura Levin MD & Joanna Harp MD

Authors
  1. Marisa Kardos Garshick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Levin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanna Harp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Harp MD .

Editor information

Editors and Affiliations

  1. Houston, Texas, USA

    Knox H. Todd

  2. Portland, Oregon, USA

    Charles R. Thomas, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Garshick, M.K., Levin, L., Harp, J. (2016). Dermatologic Emergencies in Oncologic Patients. In: Todd, K., Thomas, Jr., C. (eds) Oncologic Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-26387-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26387-8_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26385-4

  • Online ISBN: 978-3-319-26387-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation